Effects and mechanisms of total glucosides of paeony on adjuvant arthritis in rats

Journal of Ethnopharmacology

Volumn 109, Issue 3, 2007, Pages 442-448

  Xu, Hong Mei ^a,b   Wei, Wei ^a   Jia, Xiao Yi ^a   Chang, Yan ^a   Zhang, Lei ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b HEFEI UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

AA; IL 1; PGE2; TGP; TNF

Indexed keywords

ALBIFLORIN; BENZOYLPAEONIFLORIN; CONCANAVALIN A; CYCLIC AMP; FREUND ADJUVANT; HYDROXYPAEONIFLORIN; INTERLEUKIN 1; INTERLEUKIN 6; PAEONIA LACTIFLORA EXTRACT; PAEONIA RADIX; PAEONIFLORIN; PAEONIN; PLANT EXTRACT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; TOTAL GLUCOSIDE OF PAEONY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG FORMULATION; DRUG INHIBITION; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; INFLAMMATION; MALE; NONHUMAN; PAEONIA LACTIFLORA; PAW EDEMA; POLYARTHRITIS; RADIOIMMUNOASSAY; RAT; SPRAGUE DAWLEY RAT; SYNOVIOCYTE; THYMOCYTE; WESTERN BLOTTING;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELL PROLIFERATION; CYCLIC AMP; DINOPROSTONE; DRUGS, CHINESE HERBAL; GLUCOSIDES; INTERLEUKIN-1; INTERLEUKIN-6; MALE; PAEONIA; RATS; RATS, SPRAGUE-DAWLEY; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

MUS; PAEONIA LACTIFLORA; PAEONIACEAE; RATTUS;

EID: 33845996186     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2006.08.019     Document Type: Article

References (40)

1. Arakawa T., Laneuville O., Miller C.A., Lakkides K.M., Wingerd B.A., DeWitt D.L., and Smith W.L. Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells: structure and expression of the murine prostaglandin EP4 receptor gene. The Journal of Biological Chemistry 271 (1996) 29569-29575
2. Arend W.P., and Dayer J.-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor-α in rheumatoid arthritis. Arthritis Rheumatism 38 (1995) 151-160
3. Blair H.C., and Athanasou N.A. Recent advances in osteoclast biology and pathological bone resorption. Histology and Histopathology 19 (2004) 189-199
4. Bonecchi R., Bianchi G., Bordignon P.P., D'Ambrosio D., Lang R., Borsatti A., Sozzani S., Allavena P., Gray P.A., Mantovani A., and Sinigaglia F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. Journal of Experimental Medicine 187 (1998) 129-134
5. Coleman R.A., Smith W.L., and Nurumiya S. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacology Reviews 46 (1994) 205-229
6. Davies P., Bailey P., Goldenberg M., and Ford-Hutchinson A. The role of arachidonic acid oxygenation products in pain and inflammation. Annual Review of Immunology 2 (1984) 335-357
7. Dayer J.-M., and Fenner H. The role of cytokines and their inhibitors in arthritis. Baillieres Clinical Rheumatology 6 (1992) 485-516
8. Dayer J.M., Krane S.M., Russell R.G.G., and Robinson D.R. Production of collagenase and prostaglandins by a possible mechanism for bone destruction in rheumatoid arthritis. Proceedings of the National Academy of Sciences of the United States of America 73 (1976) 945-949
9. Dumont J.E., Jauniaux J.C., and Roger P.P. The cyclic AMP-mediated stimulation of cell proliferation. Trends in Biochemical Sciences 14 (1989) 67-71
10. Feldmann M., Brennan F.M., and Maini R.N. Rheumatoid arthritis. Cell 85 (1996) 307-310
11. Foey A.D., Field S., Ahmed S., Jain A., Feldmann M., Brennan F.M., and Williams R. Impact of VIP and cAMP on the regulation of TNFα and IL-10 production: implications for rheumatoid arthritis. Arthritis Research and Therapy 5 (2003) R317-R328
12. Fulkerson J.P., and Damiano P. Effect of prostaglandin E2 on adult pig articular cartilage slices in culture. Clinical Orthopaedics 179 (1983) 266-269
13. Gu W.Z., and Brandwein S.R. Inhibition of type II collagen-induced arthritis in rats by triptolide. International Journal of Immunopharmacology 20 (1998) 389-400
14. Inoue H., Takamori M., Shimoyama Y., Ishibashi H., Yamamoto S., and Koshihara Y. Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts. British Journal of Pharmacology 136 (2002) 287-295
15. Joosten L.A.B., Helsen M.M.A., Saxne T., van de Loo F.A.J., and van den Berg W.B. IL-1β blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNFα blockade only ameliorates joint inflammation. The Journal of Immunology 163 (1999) 5049-5055
16. Katsuyama M., Ikegami R., Karahashi H., Amano F., Sugimoto Y., and Ichikawa A. Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1. Biochemical and Biophysical Research Communications 251 (1998) 727-731
17. Klareskog L., Ronnelid J., and Holm G. Immunopathogenesis and immunotherapy in rheumatoid arthritis: an area in transition. Journal of Internal Medicine 238 (1995) 191-206
18. Koch A.E. Angiogenesis: implication of rheumatoid arthritis. Arthritis Rheumatism 41 (1998) 951-962
19. Kojima F., Naraba H., Sasaki Y., Beppu M., Aoki H., and Kawai S. Prostaglandin E2 is an enhancer of interleukin-1β-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblast. Arthritis Rheumatism 48 (2003) 2819-2828
20. Kurihara Y., Endo H., Akahoshi T., and Kondo H. Up-regulation of prostaglandin E receptor EP2 and EP4 subtypes in rat synovial tissues with adjuvant arthritis. Clinical and Experimental Immunology 123 (2001) 323-330
21. Li X., Zarinetchi F., Schrier R.W., and Nemenoff R.A. Inhibition of MAP kinase by prostaglandin E2 and forskolin in rat renal mesangial cells. American Journal of Physiology 269 (1995) C986-C991
22. Lippiello L., Yamamoto K., Robinson D., and Mankin H.J. Involvement of prostaglandins from rheumatoid synovium in inhibition of articular cartilage metabolism. Arthritis Rheumatism 21 (1979) 909-917
23. McCoy J.M., Wicks J.R., and Audoly L.P. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. The Journal of Clinical Investigation 110 (2002) 651-658
24. Morris A.J., and Malbon C.C. Physiological regulation of G protein-linked signaling. Physiological Reviews 79 (1999) 1373-1430
25. Müller-Decker K., Scholz K., Marks F., and Fürstenberger G. Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Molecular Carcinogenesis 12 (1995) 31-41
26. Nanki T., Nagasaka K., Hayashida K., Saita Y., and Miyasaka N. Chemokines regulate IL-6 and IL-8 production by fibroblastlike synoviocytes from patients with rheumatoid arthritis. Journal of Immunology 167 (2001) 5381-5385
27. Negishi M., Sugimoto Y., and Ichikawa A. Prostaglandin E receptors. Journal of Lipid Mediators and Cell Signaling 12 (1995) 379-391
28. Oliver S.J., and Brahn E. Combination therapy in rheumatoid arthritis: the animal model perspective. The Journal of Rheumatology Supplement 44 (1996) 56-60
29. Portanova J.P., Zhang Y., Anderson G.D., Hauser S.D., Masferrer J.L., Seibert K., Gregory S.A., and Isakson P.C. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. The Journal of Experimental Medicine 184 (1996) 883-891
30. Prabhakar U., Lipshutz D., O'leary-Bartus J., Slivjak M.J., Smith E.F., Lee J.C., and Esser K.M. Characterization of cyclic AMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase inhibitor. International Immunopharmacology 16 (1994) 805-816
31. Robinson D.R., Tashijian A.H.J., and Levine L. Prostaglandin-stimulated bone resorption by rheumatoid synovia: a possible mechanism for bone destruction in rheumatoid arthritis. The Journal of Clinical Investigation 56 (1975) 1181-1188
32. Seldon P.M., Barnes P.J., Mejk K., and Giembycz M.A. Suppression of lipopolysaccharide-induced tumor necrosis factor-α generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase. Molecular Pharmacology 48 (1995) 747-757
33. Van den Berg W.B. Anti-cytokine therapy in chronic destructive arthritis. Arthritis Research 3 (2001) 18-26
34. Wang B., Yao Y.Y., Zhou A.W., Ge Z.D., Chen M.Z., and Xu S.Y. Protective effects of total glucosides of paeony on joint damage in adjuvant arthritis rats. Chinese Journal of Pharmacology and Toxicology 10 (1996) 211-214
35. Wang Z.J., Chen M.Z., Sun G.H., and Xu S.Y. Effect of total glucosides of paeony on rheumatoid arthritis patients. Chinese Pharmacological Bulletin 10 (1994) 117-122
36. Wei W., Chen M.Z., and Xu S.Y. Pharmacological effects of isoxicam. Chinese Pharmacological Bulletin 2 (1986) 29-34
37. Wu J., Dent P., Jelinek T., Wolfman A., Weber M.J., and Sturgill T.W. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 39, 59-monophosphate. Science 262 (1993) 1065-1069
38. Yamada T., Terada Y., Homma M.K., Nonoguchi H., Sasaki S., Yuasa Y., Tomita K., and Marumo F. AVP inhibits EGF-stimulated MAP kinase cascade in Madin-Darby canine kidney cells. Kidney International 48 (1995) 745-752
39. Yoshida T. Involvement of prostaglandin E (2) in interleukin-1alpha-induced parathyroid hormone-related peptide production in synovial fibroblasts of patients with rheumatoid arthritis. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 3272-3278
40. Zitnik R.J., Zheng T., and Elias J.A. cAMP inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts. The American Journal of Physiology 264 (1993) L253-L260